Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA)
- Conditions
- Rheumatoid Arthritis
- Registration Number
- NCT02382783
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to determine how best to monitor for flares in patients with rheumatoid arthritis (RA).
- Detailed Description
This project is aimed at developing an improved multilevel care process model for the management of rheumatoid arthritis (RA) disease activity by implementing systematic self-monitoring of flare experiences by RA patients, combined with continuous patient-tailored adjustments of treatment modalities by a coordinated team of rheumatology health care providers (RHCPs).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 178
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Flare Occurrence Anticipated length of study is two years. The occurrence of flares over the follow-up time (flare rate). The Outcome Measures in Rheumatology(OMERACT-9) definition of flare will be applied to both groups to determine how many occurrences indicate worsening of disease activity, leading to initiation, change, or increase of therapy by RHCPs. This definition will allow for parallel comparisons of flare rates in both groups.
Flare-to-visit Time Anticipated length of study is two years. The flare-to-visit time will be compared between the two groups.
- Secondary Outcome Measures
Name Time Method Participant Satisfaction Three time-points: baseline, year one, and end of study. Anticipated length of study is two years. Satisfaction surveys will be provided to participants at three time-points: baseline, year one, and end of study.
Trial Locations
- Locations (1)
Mayo Clinic in Rochester
🇺🇸Rochester, Minnesota, United States
Mayo Clinic in Rochester🇺🇸Rochester, Minnesota, United States